37 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
can experience their most fulfilling life. The unit collaborates with the rare disease community around the globe to bring voice to underserved … . The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
previously. In Q3, we added an additional 31 new prescribers which brings the YTD total new prescribers to 89, the vast majority of whom are community … - steady increase in prescriber base with an additional 31 new prescribers added in Q3, 97% of whom were community-based physicians - this brings
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
in greatest need. We are proud to support the global acromegaly community on Acromegaly Awareness Day 2022.”
About AmrytAmryt is a global commercial
6-K
EX-99.5
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
published in this international journal so we can share these pivotal data with the medical and scientific community. This was the first EB study to meet its
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
% of whom are community-based physicians
Presented Mycapssa® data from OPTIMAL and MPOWERED Phase 3 trials at ENDO 2022 meeting
Announced positive long
424B4
9omu3m auk
20 May 22
Prospectus supplement with pricing info
5:06pm
424B4
6yajzb08dgfi
20 May 22
Prospectus supplement with pricing info
4:58pm
424B4
ro3daa trz
20 May 22
Prospectus supplement with pricing info
4:57pm
F-3
g90rci0wfcoe0jxf
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
tqyytrvkaygn 26hzdeq
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
iwdgnny2hogryi4a4
11 May 22
Prospectus update (post-effective amendment)
5:19pm
424B3
2zh4r8hh
31 Mar 22
Prospectus supplement
8:44am
424B3
sx5teeuofu5m569v303o
31 Mar 22
Prospectus supplement
8:44am
6-K
EX-99.4
gq07oba970sr za
31 Mar 22
Results of General Meeting
8:41am
424B3
tvvfl
28 Feb 22
Prospectus supplement
12:02pm
424B3
mi3 lv9inq7r9mi1nuh
28 Feb 22
Prospectus supplement
12:01pm
6-K
EX-99.1
d0vfk p33
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
EX-99.2
r4ms875c46ddp4o78o01
13 Sep 21
Current report (foreign)
8:48am